{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T03:13:05Z","timestamp":1789269185072,"version":"build-2803163510"},"reference-count":20,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2008,10]]},"abstract":"<jats:p><jats:bold>Abstract:\n\t\t\t\t\t<\/jats:bold> The incidence of pneumonia caused by <jats:italic>Pneumocystis carinii<\/jats:italic> (PCP) (organism now renamed <jats:italic>Pneumocystis jiroveci<\/jats:italic>) during the early period after cord blood transplantation (CBT) was studied in 120 adults. Initially 89 patients (74%) received oral administration of 2 single\u2010strength trimethoprim\u2010sulfamethoxazole (TMP\u2010SMZ) tablets twice daily from day \u221221. In 45 of 89 patients (51%), TMP\u2010SMZ administration for a scheduled duration was completed. In the remaining 44 patients (49%), however, TMP\u2010SMZ administration was discontinued prior to day \u22123 because of toxicity. Among these patients, 42 subsequently received aerosolized pentamidine (AP) on a median of day \u221213 (range, \u221220 to \u22126). Thirty\u2010one patients (26%) received AP without TMP\u2010SMZ administration on a median of day \u221214 (range, \u221221 to \u22129). None of the 120 patients were diagnosed with PCP within 100 days or 2 years after CBT; however, one patient who received AP before CBT but no prophylaxis after CBT developed cerebral toxoplasmosis on day +91. Pre\u2010transplant prophylaxis against PCP did not significantly affect transplantation\u2010related mortality or disease\u2010free survival at 2 years after CBT. The results suggest that PCP during the early period after CBT can be effectively prevented by any pre\u2010transplant prophylactic method.<\/jats:p>","DOI":"10.1111\/j.1399-3062.2008.00321.x","type":"journal-article","created":{"date-parts":[[2008,6,17]],"date-time":"2008-06-17T05:47:03Z","timestamp":1213681623000},"page":"303-307","source":"Crossref","is-referenced-by-count":13,"title":["No occurrence of <i>Pneumocystis jiroveci (carinii)<\/i> pneumonia in 120 adults undergoing myeloablative unrelated cord blood transplantation"],"prefix":"10.1111","volume":"10","author":[{"given":"A.","family":"Tomonari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Konuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Iseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,9,21]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"1225","volume-title":"Clinical Bone Marrow and Blood Stem Cell","author":"Martino R.","year":"2004"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.87.2.237"},{"key":"e_1_2_6_4_2","first-page":"1283","article-title":"The value of Pneumocystis carinii antibody and antigen detection for diagnosis of Pneumocystis carinii pneumonia after marrow transplantation","volume":"120","author":"Meyers JD","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_6_5_2","first-page":"403","article-title":"Pentamidine aerosol for prophylaxis of Pneumocystis carinii pneumonia after BMT","volume":"11","author":"Link H","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_6_2","first-page":"324","article-title":"Aerosolized pentamidine for prevention of Pneumocystis pneumonia after allogeneic marrow transplantation","volume":"7","author":"Przepiorka D","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199212243272606"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/520433"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041276"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041469"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-1001"},{"key":"e_1_2_6_12_2","first-page":"304","article-title":"Cytomegalovirus infection following unrelated cord blood transplantation for adult patients","volume":"121","author":"Tomonari A","year":"2003","journal-title":"a single institute experience in Japan"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2006.03.007"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04792.x"},{"key":"e_1_2_6_15_2","first-page":"267","article-title":"Pneumocystis carinii pneumonitis following bone marrow transplantation","volume":"10","author":"Tuan IZ","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_16_2","first-page":"64","article-title":"Possible prevention of Pneumocystis carinii pneumonia by pentamidine aerosol after bone marrow transplantation","volume":"8","author":"Mahon FX","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(00)70050-4"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1086\/313509"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1086\/321901"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000040719"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1086\/323129"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3062.2008.00321.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3062.2008.00321.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T16:29:03Z","timestamp":1696868943000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3062.2008.00321.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,21]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["10.1111\/j.1399-3062.2008.00321.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3062.2008.00321.x","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,21]]}}}